Eastwoods Consulting
Notes from the East Woods

musings on opportunities in the life science marketplace

  November  2008
  
EC border

Greetings!

This month an unfortunate wild boar helps us see the value of knowing where we are going.  Please have a read and feel free to let me know what you think.  Thanks.

Regards,

Paul Danis
Founder and Principal
 
Join Our Mailing List!
This Month's Features
Wild Boar and Focusing on the Target
Life Science Market Update
Wild Boar and Focusing on the Target
Wiled Boar

I was astonished to read how a wild Russian boar was hit by a car and killed in central Massachusetts. No one has any idea how this usually southern creature ended up roaming the local woods until he chose to cross the road.  This reminds me of how some companies bring their products into new markets only to meet hardship and untimely death. 
 
Going into new markets is a common activity for many companies that develop new technology.  The research folks come up with a good idea that gets some other folks excited leading to the development of a new product.  All is well and good until some wise guy asks, "so who is going to buy this?"  Thus, it is like the wild boar in Massachusetts exploring the markets (the woods) trying to find opportunity (food) and he ends up as sausage (he actually did).  There has to be a better way...and there is.
 
The first approach is to spend considerable time and effort as early as possible in the development program to determine the best target applications for the potential new product.  This will give the needed focus to insure that the product is of value to the customers. 
 
The second approach is to forget the technology and first look to the marketplace to determine where there is a significant problem.  Then, focus the efforts on finding a solution to the problem.  This was illustrated to me by two companies who were successful with this approach.  Ken Rapp, CEO of VelQuest heard people complaining about having to manage piles of data, results, and notes in the laboratory.  They were trying to use this information so they can make better decisions in pharmaceutical development. 
 
He then spent a few months talking to the researchers to really understand the nature of the problem.  At that point he started to develop the solution needed for these people using off-the shelf components.  When ready for the market, his electronic notebook was warmly received and success followed.  As Ken said - "begin with the end in mind."
 
The other example of this was from Stan Lapidus who is the founder of several successful life science companies.  When he raised $400,000 to start Helicos BioSciences, he spent nearly all of this determining clearly the problem that people had.  His assumption is unless you understand the targeted problem very well, you will probably be wasting money.  Helicos is currently one of the leaders in next-generation genomic sequencing.
 
So rather than wandering the woods with your new product searching for opportunity, be sure to have a clear view of the landscape and the problem that you are solving.  You don't want your products to end up as sausage.



 
Life Science Market Update

Index

October Value

Change YTD

Yearly High

Yearly Low

EC BioTools

595

-23%

802

595

EC BigPharma

663

-13%

764

663

EC Biotech

577

-17%

726

577


Life science companies have been somewhat more resistant to the downward spiral of the markets over the last month.  However, the tools sector is less in favor these days.  Earlier in the month they were all down ~20% for the year.  Tools has yet to regain some of these losses, unlike pharma and biotech.

---------------------
Many of the life science indices currently available are a mixture of various types of companies. In order to better assess the situation in the different segments, Eastwoods Consulting has created these price-weighted indices for the sectors of large pharmaceutical companies, biotech companies, and life science research tools companies.
  • EC BioTools Index - A, ABI, ACCL, AFFX, BEC, BIO, BRKR, CALP, DNEX, HBIO, HLCS, ILMN, IVGN, LMNX, PKI, QGEN, SIAL, TMO, VARI, WAT
  • EC BigPharma Index - JNJ, PFE, GSK, NVS, SNY, MRK, ABT, LLY, AZN, WYE, BMY, NVO, BAX, TEVA, SGP, RHHBY.PK
  • EB Biotech Index - DNA, AMGN, GENZ, BIIB, CEPH, GILD, BMRN, AMLN, IDXX, SEPR, OSIP, PDLI, CPHD, ALKS, REGN, MEDX, THRX, HGSI, SGMO, ENZN, NKTR
  • Prices are taken at the close of each month.
EC Border
 
About Eastwoods Consulting
Eastwoods Consulting


Eastwoods Consulting helps companies connect their technologies and products with the life science marketplace.  By focusing on the most valuable opportunities, efficiency is increased, and profits grow.
 


Copyright © 2008, Eastwoods Consulting. This publication may be freely redistributed in full or in part as long as full attribution including our contact information and web address, are included.  Eastwoods is a registered servicemark of Eastwoods Consultng.